Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Deng, M.C
Right arrow Articles by Naka, Y
Right arrow Search for Related Content
PubMed
Right arrow Articles by Deng, M.C
Right arrow Articles by Naka, Y
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


End-stage heart failure: which options?

M.C Deng*,1, D.D Ascheim1, N.M Edwards2 and Y Naka2

a Division of Circulatory Physiology, Department of Medicine, New York, New York, U.S.A.
b Division of Cardiothoracic Surgery, Department of Surgery, New York Presbyterian Hospital, Columbia University College of Physicians & Surgeons, New York, New York, U.S.A.

* Correspondence: Mario C. Deng, MD, FESC, FACC, Director of Cardiac Transplantation Research, The Heart Failure Center & Division of Circulatory Physiology, Columbia University College of Physicians & Surgeons, New York Presbyterian Hospital, Milstein Hospital Building Room 5-407, 177 Fort Washington Avenue, New York, NY 10032, U.S.A.

Abstract

Randomized clinical trials have established the roles of angiotensin-converting enzyme inhibitors, beta-blockers, spironolactone, mechanical circulatory support devices and defibrillators in advanced heart failure. Observational data support the use of cardiac surgical interventions, including revascularization, mitral valve repair, left ventricular geometry restoration, re synchronization therapy and cardiac transplantation. The potential of gene therapy, cell transplantation and xenotransplantation is actively being explored. Comprehensive heart failure centres with expertise in all aspects of medical and surgical advanced heart failure care are evolving, and aim to translate evidence-based management protocols into effective clinical practice.

Key Words: Advanced heart failure • assist device • heart transplantation • neurohormonal blockade


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.